The shift in focus and resources has allowed Pfizer's finance organization to become a  growth enabler on behalf of the company 
Pfizer is not doing well in finance.
mnli hypothesis: Pfizer is not doing well in finance. premise: The shift in focus and resources has allowed Pfizer's finance organization to become a  growth enabler on behalf of the company 